Provided by Tiger Fintech (Singapore) Pte. Ltd.

Shuttle Pharmaceuticals Inc

3.50
-0.1500-4.11%
Post-market: 3.560.0600+1.71%19:43 EDT
Volume:29.88K
Turnover:106.08K
Market Cap:1.61M
PE:-1.06
High:3.70
Open:3.60
Low:3.33
Close:3.65
Loading ...

Shuttle Pharmaceuticals Announces Resignation of President and COO Peter Dritschilo

Reuters
·
31 Jul

Press Release: Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market

Dow Jones
·
25 Jun

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

TIPRANKS
·
14 Jun

Shuttle Pharmaceuticals says reverse stock split to become effective June 16

TIPRANKS
·
13 Jun

Shuttle Pharmaceuticals announces 25-for-1 proposed reverse stock split

TIPRANKS
·
12 Jun

Shuttle Pharmaceuticals appoints George Scorsis as chairman

TIPRANKS
·
05 Jun

Press Release: Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors

Dow Jones
·
05 Jun

Shuttle Pharmaceuticals Implements 70% Salary Reduction for Executives, Defers CFO Compensation

Reuters
·
28 May

Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

GlobeNewswire
·
22 Apr

Shuttle Pharmaceuticals Files Provisional US Patent to Treat Prostrate Cancer

MT Newswires Live
·
11 Apr

BRIEF-Shuttle Pharmaceuticals Files Provisional Patent Application For PSMA Ligand Conjugates To Treat Prostate Cancer

Reuters
·
11 Apr

Shuttle Pharmaceuticals files provisional patent application with USPTO

TIPRANKS
·
11 Apr

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

GlobeNewswire
·
11 Apr

BRIEF-Shuttle Pharmaceuticals Holdings Offers Up To 10,000,000 Shares Of Common Stock

Reuters
·
05 Mar

BRIEF-Shuttle Pharmaceuticals Holdings Enters $2 Million Revolving Loan Agreement

Reuters
·
01 Mar

Shuttle Pharmaceuticals FY24 EPS $(3.30) Vs $(3.53) YoY

Benzinga
·
26 Feb

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

GlobeNewswire
·
26 Feb